ELLKF yields 35.31% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 5
Combined, ELLKF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ELLKF + MRK for your $10,000?
Ellaktor S.A., through its subsidiaries, engages in the construction and quarrying, wind energy, concession, environment, and real estate development businesses in Greece, other European countries, Gulf countries, the Americas, and Australia. The company operates through five segments: Construction, Concessions, Renewable Energy Sources (RES), Environment, and Real estate Development. It constructs bridges, motorways, metro projects, biological treatment plants, natural gas pipelines, refineries, shopping centers, casinos, tourist and hotel units, cultural centers, hospitals, airports, Olympic and athletic complexes, railway projects, tunnels, dams, port projects, energy production stations, electromechanical projects, etc.; and logistics, office, residential, industrial, and educational buildings. The company is also involved in the waste management and energy production, which include design, construction, and operation of waste treatment plant, as well as offers alternative fuel production and biomass exploitation projects. In addition, it develops, constructs, and operates wind farms; provides real estate development and services, which consists of retail parks, entertainment centers, residential complexes, exhibition centers, and offices and mixed use buildings, as well as offers consultancy and services to third parties. The company was formerly known as ELLINIKI TECHNODOMIKI TEB SA and changed its name to Ellaktor S.A. in 2008. The company is headquartered in Athens, Greece.
Full ELLKF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.